Gentipharm’s manufacturing facility spans 3,600 m², designed with advanced clean room technology and strict quality control systems to ensure the highest standards of product safety and efficacy. Our projects have been developed in collaboration with globally renowned experts such as Pliva, Proklima, and Klimaoprema from Croatia.

As a leader in the pharmaceutical industry, Gentipharm remains committed to innovation, quality, and improving healthcare standards for communities across the region.

Key Milestones in Gentipharm’s History

1992

Transitioned to a Pharmaceutical Distributor for medicinal products and devices, expanding healthcare accessibility.

2013

Achieved licensing as a pharmaceutical manufacturer, marking a new era of operations.

2007

Established the Galenic Laboratory, enhancing our ability to create pharmaceutical formulations.

2014

Earned GMP certification following inspections by the Kosovo Medicines Agency (AKPM) in collaboration with EU inspectors.

2010

Initiated the construction of the Gentipharm manufacturing facility, a significant investment in local pharmaceutical production.

2017

Expanded capabilities to include the production of sterile pharmaceutical products.

Research and Development (R&D)

At Gentipharm, our Research and Development (R&D) department is dedicated to the advancement of high-quality pharmaceutical solutions. Inspired by leading global practices in the industry, we focus on providing safe, effective, and affordable products to meet the needs of patients and healthcare providers.

Our R&D efforts are centered on:

With state-of-the-art facilities and a team of experienced professionals, Gentipharm is committed to delivering products that provide therapeutic benefits, improve health outcomes, and enhance accessibility to essential medicines. By focusing on generics, OTC products, and herbals, we strive to make healthcare solutions affordable and effective for communities worldwide.